(Q44265029)

1 December 2017

Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). (English)

1 reference

chronic renal insufficiency

1 December 2017

1 reference

5

Karen S Pieper

1 reference

1 December 2017

3

Ian J Sarembock

1 reference

1 December 2017

Donal N Reddan

1

1 reference

1 December 2017

John Conor O'Shea

2

1 reference

1 December 2017

Kathryn A Williams

4

1 reference

1 December 2017

Edward Santoian

6

1 reference

1 December 2017

William F Owen

7

1 reference

1 December 2017

Michael M Kitt

8

1 reference

1 December 2017

James E Tcheng

9

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

American Journal of Cardiology

1 December 2017

1 reference

1 December 2017

91

1 reference

1 December 2017

1

1 reference

1 December 2017

17-21

1 reference

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Risks associated with renal dysfunction in patients in the coronary care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Poor long-term survival after acute myocardial infarction among patients on long-term dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Long-term outcome of dialysis patients in the United States with coronary revascularization procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Subgroup analysis and other (mis)uses of baseline data in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Strategies for subgroup analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

[Rate of restenosis after PTCA in patients with terminal renal failure. A quantitative coronary angiography study]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Therapy for cardiovascular disease in patients with chronic kidney disease: appropriate caution or the absence of data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Disposition of 14C-eptifibatide after intravenous administration to healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Pharmacokinetics of heparin and low molecular weight heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Hematologic aspects of end-stage renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

Misleading subgroup analyses in GISSI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902991-0

10.1016/S0002-9149(02)02991-0

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference